// App-Quantinova.ai

: Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes

Researchers

Presenter

  • Elena Riva

Principal Investigators

  • Termanini Alberto

  • Lorenzo Dall'Olio

  • Alessandra Merlotti

  • Austin Kulasekararaj

  • Michela Calvi

  • Clara Di Vito

  • Daoud Rahal

  • Arturo Bonometti

  • Giorgio Croci

  • Emanuela Boveri

  • Umberto Gianelli

  • Maurilio Ponzoni

  • Antonio Russo

  • Benedetta Tinterri

  • Francesca Re

  • Elisabetta Sauta

  • Elena Saba

  • Erica Travaglino

  • Marta Ubezio

  • Alessia Campagna

  • Luca Lanino

  • Giulia Maggioni

  • Cristina Astrid Tentori

  • Chiara Milanesi

  • Nicla Manes

  • Saverio D'Amico

  • Francesca Ficara

  • Laura Crisafulli

  • Domenico Mavilio

  • Enrico Lugli

  • Armando Santoro

  • Maria Diez-Campelo

  • Guillermo Sanz

  • Francesc Sole

  • Uwe Platzbecker

  • Valeria Santini

  • Shahram Kordasti

  • Pierre Fenaux

  • Torsten Haferlach

  • Daniel Remondini

  • Castellani Gastone

  • Matteo G. Della Porta

Medical Centers

  • MLL Munich Leukemia Laboratory, Munich, Germany

  • Pathology, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy

  • Pathology Unit, San Raffaele Scientific Institute, Milano, Italy

  • Department of Experimental and Clinical Medicine, MDS Unit, Hematology, AOU Careggi - University of Florence, Firenze, Italy

  • Human Technopole, Milan, Italy

  • Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy

  • Systems Cancer Immunology, Comprehensive Cancer Centre, King's College London, London, United Kingdom

  • Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

  • Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, Bologna, Italy

  • Institute of Surgical Pathology, Pavia, ITA

  • Humanitas Clinical and Research Center, Milan, Italy

  • King's College Hospital, National Institute for Health and Care Research/Wellcome King's Clinical Research Facility, London, United Kingdom

  • Physics and Astronomy Department, University of Bologna, Bologna, Italy

  • Department of Hematology. Salamanca-IBSAL university hospital, Salamanca, Spain

  • Pathology Unit, Department of Pathophysiology and Transplantation, University of Milan and Fondazione IRCCS, Ca' Granda - Maggiore Policlinico, Italy, Milan, Italy

  • Hematology Deparment, Health Research Institute La Fe, Valencia, Spain

  • Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy

  • Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center, Rozzano, Italy

  • IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, ITA

  • Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

  • Artificial Intelligence Center, Humanitas Research Hospital, Rozzano (Milan), Italy

  • Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France

  • University of Milan, Milan, Italy

  • MDS Group

Locations

  • Germany

  • Italy

  • United Kingdom

  • Spain

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved